Paracellin-1 (PCLN-1) belongs to the claudin family of tight junction proteins and possibly plays a critical role in the reabsorption of magnesium and calcium. So far, the physiological properties of PCLN-1 have not been clarified. In the present study, we investigated whether PCLN-1 is associated with ZO-1. We also investigated whether 45 Ca 2؉ transport across the paracellular barrier is affected by this association. In vitro binding analysis using glutathione S-transferase fusion protein showed that the C-terminal TRV sequence, especially Thr and Val residues, of PCLN-1 interacts with ZO-1. Next, PCLN-1 was stably expressed in Madin-Darby canine kidney cells using a FLAG tagging vector. ZO-1 was co-immunoprecipitated with the wild-type PCLN-1 and the alanine substitution (TAV) mutant. However, mutants of the deletion (⌬TRV) and the alanine substitution (ARV and TRA) inhibited the association of PCLN-1 with ZO-1. Confocal immunofluorescence demonstrated that the wild-type PCLN-1 and the TAV mutant localized in the tight junction along with ZO-1, but the ⌬TRV, ARV, and TRA mutants were widely distributed in the lateral membrane including the tight junction area. Interestingly, monolayers of cells expressing the wild-type PCLN-1 and the TAV mutant showed higher activities of 45 Ca 2؉ transport from apical to basal compartments, compared with those expressing the ⌬TRV, ARV, and TRA mutants and the mock cells.
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2؉ transport was inhibited by increased magnesium concentration suggesting that magnesium and calcium were competitively transported by PCLN-1. It was noted that a positive electrical potential gradient enhanced 45 
2؉ transport from apical to basal compartments without affecting the opposite direction of transport. Thus, PCLN-1 localizes to the tight junction followed by association with ZO-1, and the PCLN-1⅐ZO-1 complex may play an essential role in the reabsorption of divalent cations in renal epithelial cells.
Magnesium is an important cofactor for various enzymes. The bodies magnesium balance is regulated by the kidney, which adapts magnesium excretion based on net magnesium absorption from intestine. Renal magnesium filtrated in the glomeruli is predominantly reabsorbed through the paracellular pathway in the thick ascending limb (TAL) 1 of Henle (1). However, the molecular nature of magnesium reabsorption in TAL was unknown for many years.
Tight junction (TJ) forms apical junctional complexes in epithelial and endothelial cells and plays a central role in the maintenance of barrier and cell polarity (2, 3) . These functions are facilitated by occludin and claudin family. So far, at least 22 mammalian isoforms of claudin have been identified, and their spatial distribution patterns in some epithelial tissues have been clarified. Paracellin-1 (PCLN-1), cloned by Simon et al. (4) , is a most cogent protein that undertakes magnesium reabsorption, because (1) homozygous mutations in the PCLN-1 gene are associated with a rare familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), and (2) PCLN-1 is exclusively expressed in the TJ of TAL. PCLN-1 belongs to the claudin family (named claudin-16), which composes a TJ strand and is the most distantly related member of this family. Amino acid homology between PCLN-1 and individual claudin is very low (10 -18%), but these proteins have a consensus PSD95/DglA/ZO-1-like domain (PDZ)-binding motif at the C terminus (5) .
Protein-protein interactions mediated by the PDZ-binding motif occur through the PDZ domains in multiple members of the membrane-associated guanylate kinases (6) . Membraneassociated guanylate kinases contain several PDZ domains, an SH3 domain, and a C-terminal guanylate kinase homology region that may act as a protein-binding domain (7, 8) . Among them, ZO-1 and ZO-2 are localized at the TJ area and they may anchor transmembrane proteins, such as occludin and claudin family. Thus, the interactions between transmembrane proteins and cytoplasmic molecules may modulate paracellular permeability.
The direct binding of ZO-1 with the C terminus (YV sequence) of claudin-1-8 has been revealed by an in vitro binding assay using glutathione S-transferase (GST) fusion protein and in vivo immunofluorescence analysis (9) . However, the C terminus (TRV sequence) of PCLN-1 is different from that of other proteins in the claudin family, and the function of PCLN-1 has not been clarified yet. In the present study, we found the association between ZO-1 and the C-terminal TRV sequence of PCLN-1. Furthermore, the function of PCLN-1 was established by measurements of transepithelial electrical resistance (TER) and 45 Ca 2ϩ transport.
EXPERIMENTAL PROCEDURES
Materials-Rabbit polyclonal ZO-1 antibody was obtained from Zymed Laboratories Inc. Mouse monoclonal FLAG M2 antibody and G418 sulfate were from Sigma. Fluorescein isothiocyanate-labeled antirabbit IgG was from Kirkegaard & Perry Laboratories (Guildford, UK). Goat polyclonal GST antibody, protein G-Sepharose beads, and 45 CaCl 2 was from Amersham Biosciences. Goat polyclonal occludin antibody and goat polyclonal PCLN-1 antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Lipofectamine 2000 was from Invitrogen. All other reagents were of the highest grade of purity available.
Plasmid cDNA Constructs-Rat PCLN-1 cDNA containing the whole open reading frame was amplified by the reverse transcriptase-PCR from rat kidney mRNA using the set of primers, 5Ј-CGATATCCATGA-AGGATCTTCTTC-3Ј (sense) and 5Ј-CCGGTCGACTTACACTCTCGTG-TC-3Ј (antisense). The PCLN-1 cDNA was subcloned into the mammalian expression vector, pCMV-Tag2A (BD Biosciences Clontech), containing the FLAG epitope. Additional FLAG-PCLN-1 cDNA encoding PCLN-1 with point substitutions in the C-terminal PDZ-binding motif (substitutions are underlined, FLAG-PCLN-1-ARV, FLAG-PCLN-1-TAV, FLAG-PCLN-1-TRA) and with the deletion mutant (FLAG-PCL-N-1-⌬TRV) were constructed by PCR using the above sense and the antisense primers (ARV, 5Ј-CCGGTCGACTTACACTCTCGCGTC-3Ј; TAV, 5Ј-CCGGTCGACTTACACTGCCGTGTC-3Ј; TRA, 5Ј-CCGGTCG-ACTTACGCTCTCGTGTC-3Ј; ⌬TRV, 5Ј-CGTCGACTTAGTCTACAGC-GTAC-3Ј). Fusion proteins of the C terminus of PCLN-1 with GST were constructed by subcloning PCR amplified DNA fragments into pGEX-4T-1 (Amersham Biosciences) to yield GST-PCLN-1-⌬TRV, GST-PCLN-1-TRA, GST-PCLN-1-TAV, and GST-PCLN-1-ARV, respectively. All wild-type and mutant PCLN-1 constructs were verified by DNA sequencing.
In Vitro Binding Assay-The plasmids of GST-PCLN-1-⌬TRV, GST-PCLN-1-ARV, GST-PCLN-1-TAV, and GST-PCLN-1-TRA were transformed in Escherichia coli BL21. GST fusion proteins were purified with glutathione-Sepharose 4B beads (Amersham Biosciences). The beads were incubated with lysate of Madin-Darby canine kidney (MDCK) cells in a buffer composed of 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Nonidet P-40, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor mixture (Sigma) for 4 h at 4°C. Then, bound proteins were eluted with a sample buffer and applied to the SDS-polyacrylamide gel. Proteins were blotted onto a polyvinylidene difluoride membrane and incubated for 1 h with each primary antibody followed by peroxidase-conjugated secondary antibody. The blots were visualized as described in the Western blotting section.
Cell Culture and Transfection-MDCK cells were obtained from the European Collection of Cell Cultures (#84121903, Wiltshire, UK). Cells were grown in Dulbecco's modified Eagle's medium (Sigma) supplemented with 5% Fetal Clone III (HyClone Laboratories, Logan, UT), 0.07 mg/ml penicillin-G potassium, and 0.14 mg/ml streptomycin sulfate in a 5% CO 2 atmosphere at 37°C. MDCK cells were transfected with expression plasmids using Lipofectamine 2000 as indicated in the manufacture's protocol. Stable transfectants were selected with 0.5 mg/ml G418 sulfate and maintained in the continuous presence of the selecting drug. Cell lines expressing FLAG-tagged protein were screened by Western blotting.
Preparation of Membrane Fraction and ImmunoprecipitationWhole membrane fraction was prepared from MDCK cells on day 7 in culture as described previously (10) . The samples were solubilized in a lysis buffer containing 1% Triton X-100, 150 mM NaCl, 0.5 mM EDTA, and 50 mM Tris-HCl (pH 8.0) and incubated with protein G-Sepharose beads and an antibody specific for GST at 4°C for 1 h with gentle rocking. After centrifugation at 6000 ϫ g for 1 min, the pellet was washed four times with the lysis buffer. The pellet was solubilized in the sample buffer for SDS-polyacrylamide gel electrophoresis. Protein concentration was measured using the protein assay kit (Bio-Rad Laboratories) with bovine serum albumin as the standard.
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting-SDS-polyacrylamide gel electrophoresis was carried out as described previously (11) . In brief, whole membrane fractions (30 g) or immunoprecipitants were applied to the SDS-polyacrylamide gel. Proteins were blotted onto a polyvinylidene difluoride membrane and incubated for 1 h with each primary antibody followed by a peroxidase-conjugated secondary antibody. Finally, the blots were stained with the ECL Western blotting kit from Amersham Biosciences.
Immunofluorescence Microscopy-The cells grown on cover glass for 7 days were washed twice with phosphate-buffered saline supplemented with 0.5 mM CaCl 2 and 0.5 mM MgCl 2 prior to fixation with 3% paraformaldehyde for 7 min at room temperature. After permeabilization with 0.3% Triton X-100 for 15 min and blocking with 5% skim milk in phosphate-buffered saline for 30 min, the cells were incubated with an anti-ZO-1 antibody and an anti-FLAG antibody (final dilution 1/100) for 60 min at room temperature. They were then washed three times with phosphate-buffered saline, followed by incubation with Texas Redlabeled anti-goat IgG and fluorescein isothiocyanate-labeled anti-rabbit IgG in a blocking solution (dilution 1/100) for 60 min. Immunolabeled cells were visualized on an LSM 510 confocal microscope (Carl Zeiss, Germany) set with the appropriate filter for Texas Red (543 nm excitation, 585-615 nm emission filter) and fluorescein isothiocyanate (488 nm excitation, 530 nm emission filter). Images were further processed using Adobe Photoshop (Adobe System, Inc).
Measurement of TER and Transepithelial Transport Assay-MDCK cells were plated at confluent densities on transwells with polyester membrane inserts (Corning Life Sciences, Acton, MA). TER was measured three times for each well at indicated times using a Millicell-ERS epithelial volt-ohmmeter (Millipore, Bedford, MA), and averaged values were collected. TER values (ohm ϫ cm 2 ) were normalized by the area of the monolayer and calculated by subtracting the blank values from the filter and the bathing medium. Transepithelial transport of 45 Ca 2ϩ across confluent MDCK cells was evaluated as described previously (12) . Briefly, at time 0, a transport buffer containing 0.5 Ci/ml 45 Ca 2ϩ was poured into the filter well or the outside compartment. The transport buffer contained 140 mM NaCl, 5.8 mM KCl, 0.34 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 1 mM CaCl 2 , 1 mM MgCl 2 , 25 mM glucose, and 20 mM Hepes, pH 7.4. As indicated, the concentration of MgCl 2 was changed from 0 to 10 mM. The reverse compartment was filled with the transport buffer without 45 Ca 2ϩ , CaCl 2 , and MgCl 2 . The filter plates were shaken horizontally at a frequency of 50 oscillations/min at room temperature. To evaluate the permeability of the monolayers, the opposite compartment media were collected after indicated periods. The amount of 45 Ca 2ϩ was determined with a liquid scintillation counter.
Electrophysiological Studies with the Ussing Chamber-Cells were plated at confluent densities on transwells with polyester membrane inserts. The filter rings were detached and mounted in Ussing cham- 
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bers that were incubated in the transport buffer at 37°C. The fluid volume on each side of the filter was 4 ml. 45 Ca 2ϩ transport was measured under short-circuit conditions with an amplifier (CEZ9100, Nihon Kohden, Tokyo, Japan). The transepithelial voltage was clamped at Ϫ10, 0, or ϩ10 mV. A time 0, the transport buffer containing 0.5 Ci/ml 45 Ca 2ϩ was added to one side. After 30 min, 1 ml of the transport solution was collected from the trans compartment for liquid scintillation counting.
Statistics-Results are presented as means Ϯ S.E. Differences between groups were analyzed by one-way analysis of variance, and correction for multiple comparison was made using Tukey's multiple comparison test. Significant differences were assumed at p Ͻ 0.05.
RESULTS
Association of the C-terminal Domain of PCLN-1 with ZO-1-
PCLN-1 has a typical PDZ-binding motif, TRV, at the C terminus. Here we examined whether the C terminus of PCLN-1 can associate with ZO-1. The cytoplasmic C-terminal domain of PCLN-1 was expressed as a fusion protein with GST and immobilized on glutathione-Sepharose beads (Fig. 1A) . ZO-1 associated with the wild-type PCLN-1 but not with GST alone (Fig. 1B) . The alanine substitution mutant for arginine (TAV) of the PDZ-binding motif bound to ZO-1, similarly to the wildtype, but the deletion mutant (⌬TRV) and the alanine substitution mutants for threonine (ARV) or valine (TRA) did not. Our point substitution studies indicated that C-terminal threonine and valine are critical residues in the association of PCLN-1 with ZO-1.
Co-immunoprecipitation of PCLN-1 with ZO-1-It was reported that myc-tagged or hemagglutinin-tagged claudin family proteins were concentrated with occludin at TJ when they were introduced into MDCK cells (13, 14) . We examined whether the C-terminal cytoplasmic domain of PCLN-1 affects the localization of PCLN-1 at TJ. The wild-type and the mutants of FLAG-tagged PCLN-1 were stably expressed in MDCK cells. These cell lines equally expressed FLAG-tagged PCLN-1 proteins (Fig. 2) . Mock MDCK cells showed no expression of endogenous PCLN-1. The introductions did not affect endogenous occludin and ZO-1 expressions. ZO-1 was co-immunoprecipitated with the wild-type PCLN-1 indicating that exogenous PCLN-1 could interact with endogenous ZO-1. ZO-1 was also co-immunoprecipitated with the TAV mutant. By contrast, ZO-1 could not be co-immunoprecipitated with the ⌬TRV, ARV, and TRA mutants. These results are similar to those of the GST pull-down assay (Fig. 1) indicating that the association of PCLN-1 with ZO-1 requires the C-terminal threonine and valine residues of PCLN-1.
Association of PCLN-1 with ZO-1 Is Essential for the Localization of PCLN-1 at TJ-The deletion mutants of the cytosolic C-terminal domain of occludin and claudin-1 inhibited the association between occludin and ZO-1 and the localization of these molecules at TJ (13, 15) . However, these mutants were expressed in the lateral membranes without binding to ZO-1. We examined the localization of FLAGtagged PCLN-1 in MDCK cells. Expression levels of the wildtype PCLN-1 and the mutants were same as judged from the levels of FLAG expression (Fig. 3, green fluorescence) . These results are similar to those of the Western blotting (Fig. 2) . The xz-scan images showed that merged yellow spots (Fig. 3 ) appeared near the most apical regions in the wild-type and TAV mutant, indicating these proteins were co-localized with ZO-1 at the TJ. In contrast, green fluorescence of merged images in the middle position was detected in mutants of ⌬TRV, ARV, and TRA. Furthermore, these mutants were widely distributed in the lateral membrane including the TJ area, as shown by xz-scan imaging, indicating that PCLN-1 is distributed in the plasma membrane without binding to ZO-1. These results suggest that the association of PCLN-1 with ZO-1 is necessary for the concentration of PCLN-1 at TJ.
Expression of PCLN-1 Increases TER-
The mock and PCLN-1-transfected cells were cultured in transwell inserts. In the mock cells, the TER value rose during 3 days and reached a maximum (139.2 Ϯ 4.8 ohm ϫ cm 2 ). TER then decreased to a value of 70.1 Ϯ 2.2 ohm ϫ cm 2 after 7 days. This value remained constant for up to 2 weeks after plating. The values and the pattern of time-dependent change of TER were similar to those in previous reports (16 -18) . The peak and steady state values of TER were compared among mock, wild-type, and mutant cells (Fig. 4, A and B) . In the wild-type and TAV mutants, both peak and steady states values of TER were higher than those in the mock, ⌬TRV, ARV, and TRA mutants. These results indicated that the barrier function was enhanced by the expression of wild-type and TAV mutant at TJ. transport from apical to basal compartments increased time dependently in mock cells (Fig. 5A) . In the cells expressing wild-type PCLN-1, 45 Ca 2ϩ transport from apical to basal compartments was higher than that of mock cells. On the contrary, the values of 45 Ca 2ϩ transport from basal to apical compartments were the same between the mock cells and the cells expressing the wild-type PCLN-1 (Fig. 5B) . At 60-min time points, the net 45 Ca 2ϩ transport values from apical to basal compartments in the wild-type and TAV mutant were significantly higher than those in the mock, ⌬TRV, ARV, and TRA mutants (Fig. 5C ). These results indicate that the association of PCLN-1 with ZO-1 is necessary for the functional expression of PCLN-1 protein in MDCK cells. Next, we examined the effect of extracellular magnesium concentration on 45 Ca 2ϩ transport. The addition of MgCl 2 in the apical compartment led to a decrease in 45 Ca 2ϩ transport in cells expressing the wild-type PCLN-1 (Fig. 6A) . However, the change in 45 Ca 2ϩ transport by the addition of MgCl 2 was not observed in the mock cells. It was noted that 45 Ca 2ϩ transport from basal to apical compartments was also unaffected by MgCl 2 . These results indicated that the PCLN-1⅐ZO-1 complex competitively transports calcium and magnesium from apical to basal compartments.
Expression of PCLN-1 Increases
Effect of the Electric Potential Gradient on Transepithelial 45 Ca
2ϩ Transport-As shown in Fig. 5 , PCLN-1 enhanced unidirectional 45 Ca 2ϩ transport from apical to basal compartments. Next, we examined the effects of electrical potential gradients on 45 Ca 2ϩ transport. The cell layer on the membrane filter was mounted in Ussing chambers and bathed with the transport solution. The values of transepithelial potential in the mock cells and the cells expressing the wild-type PCLN-1 were 0.45 Ϯ 0.03 mV (n ϭ 18) and 0.43 Ϯ 0.03 mV (n ϭ 18) with the apical surface negative, respectively. When the transepithelial potential was clamped at 0 mV, the 45 Ca 2ϩ transport from apical to basal compartments in the PCLN-1 expressing cells was larger than that in the mock cells (Fig. 7A) . The difference in 45 Ca 2ϩ transport became larger at ϩ10 mV. It was noted that 45 Ca 2ϩ transport from basal to apical compartments of the mock cells was similar to that of the cells expressing the wild-type PCLN-1 (Fig. 7B) . These results suggest that divalent cations are reabsorbed by PCLN-1 according to the electrical potential gradient. 
DISCUSSION
The paracellular pathway of renal tubules has paradoxical roles, the reabsorption of solutes and acting as a transepithelial barrier. Unlike transmembrane ion channels, the paracellular pathway shows selectivity for net charges rather than for specific ions. These functions are facilitated by occludin and claudin family. PCLN-1 is a cogent protein that undertakes calcium and magnesium reabsorption in the TAL of Henle. Various mutations of PCLN-1 within the extracellular loops or the transmembrane domains have been identified in patients with FHHNC (4, 19, 20) . Recently, Muller et al. (21) reported a novel mutation at the C-terminal Thr residue of the PDZ-binding motif that inhibits the association of PCLN-1 with ZO-1 in patients with idiopathic hypercalciuria. So far, biochemical and cell biological characterizations of the PDZ-binding motif of PCLN-1 have not been examined. In the present study, we revealed that the Thr and Val residues, but not the Arg residue, of the PDZ-binding motif are essential for the association of PCLN-1 with ZO-1 using the GST pull-down assay and immunoprecipitation analysis. If PCLN-1 is free from ZO-1, most of the PCLN-1 is not localized in TJ but in the lateral membrane of MDCK cells. However, only a small quantity of mutants that are free from ZO-1 may localize at TJ, because the merged yellow fluorescence of PCLN-1 and ZO-1 was indistinctly detected near the apical side (Fig. 3) . Similarly, myc-tagged claudin-1, which may interfere with its association with ZO-1, has been reported to be distributed in the lateral membrane of MDCK cells (18) . Our results suggest that ZO-1 plays a critical role in the localization of PCLN-1 at TJ.
The properties of claudin-1, -2, -4, -8, and -15 have been well characterized in the over-expression model of MDCK cells. Claudin-1 increases TER, and the flux of small solutes such as mannitol and fluorescein isothiocyanate-dextran (18) . Claudin-4 decreases paracellular conductance resulting from a selective decrease in Na ϩ permeability (22) . Claudin-8 increases TER via the reduction of paracellular permeability to monovalent inorganic and organic cations and divalent cations (16) . In contrast, claudin-2 increases paracellular cation conductance without changing mannitol flux (23) . Our present results showed for the first time that the PCLN-1⅐ZO-1 complex increases TER and the paracellular permeability of divalent cations. Thus, the effects of claudins on TER and paracellular ion selectivity are type-specific. Why did PCLN-1 expression cause increased divalent cation transport despite an increase in TER in MDCK cells? We hypothesize that PCLN-1 expression increases protein density in restricted TJ areas, because it did not change the expression level of endogenous occludin, and PCLN-1 constructs a pore that is selectively permeable to divalent cations. In the mock cells and cells expressing wild-type PCLN-1, the removal of Na ϩ or Cl Ϫ from the bathing media increased TER, but Mg 2ϩ removal did not change TER (data not shown). Similarly, paradoxical increases in TER and the paracellular flux of mannitol and dextran were observed in MDCK cells expressing occludin (24) and claudin-1 (18) .
PCLN-1 did not affect endogenous ZO-1 levels, consistent with previous reports on claudin-1 (18) and claudin-4 expression (22) . The deletion of the PDZ-binding motif (YV) at the C terminus of claudin-1-8 was enough to inhibit the association of claudins with ZO-1, but the mutants could be still distributed at the TJ (9) . On the contrary, PCLN-1 mutants with the substitution of Thr for Arg at the C terminus led to lysosomal mistargeting (21) . We found that PCLN-1 mutants can be incorporated in TJ to some extent without binding to ZO-1 (Fig.  3) but could not record lysosomal mistargeting, because the mutants were widely distributed in the lateral membrane. The mutants unbound to ZO-1 did not increase both TER and divalent cation permeability. We suggest that ZO-1 is arranged by the dissociation of other complexes and concentrates PCLN-1 at the TJ. However, it is difficult to prove this hypothesis, because the stoichiometry of occludin and claudins in a single TJ fibril and their oligomerization into heteromeric and heterotypic assemblies are still unknown.
The reabsorption of magnesium and calcium in TAL occurs passively via the paracellular pathway under the apical-positive transepithelial potential difference (25, 26) . Our present results indicate that calcium can be transported across monolayers of MDCK cells grown on permeable filters. PCLN-1 increased calcium transport from apical to basal compartments without affecting transport from basal to apical compartments. Furthermore, the apical-positive potential gradient enhanced calcium transport from apical to basal compartments. Interestingly, magnesium inhibited calcium transport in a dose-dependent manner, suggesting that PCLN-1 recognizes divalent positive charges. Negative residues on its extracellular loops are suggested to form paracellular channels selective for divalent cations (4) . In the case of claudin-4, substitution of a negative charge for a positive one at position 65 in the first extracellular loop increases paracellular Na ϩ permeability (27) . On the contrary, substitutions of positive for negative charges at three positions in the first extracellular loop of claudin-15 increase Cl Ϫ permeability. We hypothesize that the first extracellular loop of PCLN-1 looks toward the apical side and PCLN-1 can recognize divalent cations in the apical compartment. In addition, the elevation of divalent cations in the basal compartment may inhibit calcium transport via PCLN-1. The extracellular calcium/polyvalent cation-sensing protein is expressed in the basal membrane of epithelial cells in the proximal tubule, TAL, and distal tubule (28) . It has been reported that the elevation of either basal calcium or magnesium decreases the reabsorption of calcium and magnesium in TAL (29) . Further studies are required to clarify the residues involved in the recognition of divalent cations in PCLN-1.
In conclusion, the expression of the wild-type and TAV mutant of PCLN-1 increased TER and divalent cation permeability in accordance with the association between PCLN-1 and ZO-1, indicating that both Thr and Val residues at the C terminus of PCLN-1 are necessary for constructing the protein complex of functional TJ. Calcium transport from apical to basal compartments was regulated by the transepithelial potential gradient. In patients with FHHNC, mutations of PCLN-1 cause renal magnesium wasting, resulting in the development of nephrocalcinosis. The PCLN-1⅐ZO-1 complex at TJ may be essential for the reabsorption of divalent cations in renal epithelial cells.
